LIFT vs advancement flap for high transsphincteric fistula

What is known

• A meta-analysis of AF and LIFT for cryptoglandular and Crohn's high perianal fistulas reported lower incontinence with LIFT (1.6%) than AF (7.8%) in CD fistulas. ^1,2
• Systematic-review LIFT healing in CD is roughly 67–76%; AF healing in CD series is 59–80%, with a pooled ~64% mean at 29 months. ^1,3,4
• A retrospective review (Tan et al.) after seton placement found AF success 93.5% vs LIFT 62.5% (p=0.006), but LIFT had fewer postoperative complications and is technically simpler. ³
• AF success in CD is limited to patients without proctitis or anorectal stenosis; LIFT applicability is limited by multiple tracts/branch points common in CD. ^1,2

What is unknown / caveats

• Tan series favors AF for healing (93.5% vs 62.5%) while pooled series show comparable or LIFT-favorable profiles
• No adequately powered head-to-head RCT of LIFT vs AF isolated to CD high transsphincteric fistulas in the retrieved evidence
• CD healing data for both techniques rests largely on small series with variable follow-up and inconsistent incontinence measurement
• AF outcomes are worse in CD than in cryptoglandular disease and require absence of proctitis/stenosis
• The retrieved evidence does not resolve which technique maximizes healing in CD specifically.

References

1. Rinebold E, Huang AL, Hahn SJ. How to Approach the Difficult Perineum in Crohn's Disease. Clin Colon Rectal Surg. 2025;38(2):148-159. PMID: 39944307.

2. Stellingwerf ME, van Praag EM, Tozer PJ, Bemelman WA, Buskens CJ. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas. BJS Open. 2019;3(3):231-241. PMID: 31183438.

3. Busbait S. Surgical Management of Perianal Crohn's Disease: Current Evidence and Future Directions. Acta Inform Med. 2024;32(3-4):215-220. PMID: 40061009.

4. Wetwittayakhlang P, Al Khoury A, Hahn GD, Lakatos PL. The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. J Clin Med. 2022;11(11). PMID: 35683433.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.